GM-CSF With Post-Transplant Cyclophosphamide
GM-CSF With Post-Transplant Cyclophosphamide
Recruiting · NCT04237623 · Registry updated 2026-04-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GM-CSF With Post-Transplant Cyclophosphamide | Transplant-Related Hematologic Malignancy | Recruiting | Phase 2 | 2026-04-16 | NCT04237623 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Northside Hospital, Inc. | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Northside Hospital | Atlanta | United States | 134 |